A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2004
11/24/2004	EP1478764A2 Humanized collagen antibodies and related methods
11/24/2004	EP1478406A1 Compositions for delivery of therapeutics and other materials, and methods of making and using the same
11/24/2004	EP1478405A2 Beta-homolysine conjugates and their use as transport enhancer
11/24/2004	EP1478404A1 Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
11/24/2004	EP1478403A1 Responsive microgel and methods related thereto
11/24/2004	EP1478402A1 Preparation for oxidation-sensitive compounds and method for making same
11/24/2004	EP1478399A1 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
11/24/2004	EP1478398A1 New medicinal compositions on the basis of anticholinergic agents and egfr kinase inhibitors
11/24/2004	EP1478394A2 Polypeptide formulation
11/24/2004	EP1478393A2 Anti-pathogen treatements
11/24/2004	EP1478383A2 Compositions and methods for promoting myocardial and peripheral angiogenesis
11/24/2004	EP1478378A2 Anti-allergic complex molecules
11/24/2004	EP1478372A1 Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound
11/24/2004	EP1478356A2 Therapeutic compounds
11/24/2004	EP1478353A1 Sustained release pharmaceutical composition
11/24/2004	EP1478352A1 Pharmaceutical dosage form and method for the production thereof
11/24/2004	EP1478350A1 Pharmaceutical dosage forms comprising tablet core having a tensile strength below 38 n/sqcm and a coating to protect the soft core
11/24/2004	EP1478347A1 Dry granulated formulations of azithromycin
11/24/2004	EP1478346A1 Fast disintegrating tablets
11/24/2004	EP1478345A1 Novel pharmaceutical dosage forms and method for producing same
11/24/2004	EP1478344A2 Melt extrusion consisting of salts of active ingredients
11/24/2004	EP1478343A2 Compositions and methods for delivery of poorly water soluble drugs and methods of treatment
11/24/2004	EP1478342A1 Sterile filtered nanoparticule formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
11/24/2004	EP1478340A1 Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions
11/24/2004	EP1478339A1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
11/24/2004	EP1478328A2 Bioactive keratin peptides
11/24/2004	EP1478314A2 Therapeutical polyanhydride compounds for drug delivery
11/24/2004	EP1478305A2 Therapeutic polyesters and polyamides
11/24/2004	EP1478276A2 Novel targeted compositions for diagnostic and therapeutic use
11/24/2004	EP1478233A2 Method for administering glp-1 molecules
11/24/2004	EP1478229A2 Improved synthesis of polyanhyrides
11/24/2004	EP1450846A4 Self-assembling polymers, and materials fabricated therefrom
11/24/2004	EP1430082A4 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
11/24/2004	EP1221917B1 Drug delivery device
11/24/2004	EP1214340B1 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
11/24/2004	EP1214078B1 Formulations for parenteral use of estramustine phosphate and amino acids
11/24/2004	EP1148106B1 Pressure-sensitive adhesive composition and moisture-permeable pressure-sensitive adhesive tape, pressure-sensitive adhesive drug composition, and pressure-sensitive adhesive tape preparation each containing the composition
11/24/2004	EP1143962B1 Parenteral solution of propofol (2,6-diisoprophylphenol) and 2.5-di-0-methyl-1.4;3.6-dianhydro-d-glucitol as a solvent
11/24/2004	EP1137442B1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative
11/24/2004	EP1100465B1 Medicinal aerosol formulations
11/24/2004	EP1079805B1 Pharmaceutical composition comprising factor viii and neutral liposomes
11/24/2004	EP1026945A4 Improved iodine antimicrobial compositions containing nonionic surfactants and halogen anions
11/24/2004	EP0989846B1 Non-irritating cosmetic and pharmaceutical compositions
11/24/2004	CN1549829A Chitosan-thio-amidine conjugates and their cosmetic as well as pharmaceutic use
11/24/2004	CN1549826A Compositions and methods of treating diabetes
11/24/2004	CN1549823A Production of high molecular mass lectins
11/24/2004	CN1549723A Modified interleukin-1 receptor antagonist (IL-1RA) with reduced immunogenicity.
11/24/2004	CN1549712A Antitumor agents and process for producing the same
11/24/2004	CN1549710A Compositions comprising pectin and ascorbic acid
11/24/2004	CN1549706A Process for coating solid particles
11/24/2004	CN1549705A Extended release oral dosage form
11/24/2004	CN1549704A Stabilized oral suspension formulation
11/24/2004	CN1549703A 药物输送体系 Drug delivery system
11/24/2004	CN1548367A Nano level active carbon and its prepn and use
11/24/2004	CN1548158A Re-emulsifying carrier for homogeneous and stable hydrophilic medicine and its prepn process
11/24/2004	CN1548157A SARS resisting medicine action target and its preventing and treating medicine
11/24/2004	CN1548155A Vaccine composition stable at normal temperature and its prepn
11/24/2004	CN1548057A Transfusing agent of active carbon and its prepn and application in preparing cancer-treating medicine
11/24/2004	CN1177046C Enhanced virus-mediated DNA transfer
11/24/2004	CN1177002C Antimicrobial composition
11/24/2004	CN1176956C Hard capsule containing vinyl ester and polyether polymer, its use and production process
11/24/2004	CN1176720C Hyacinth bletilla micro-balls for liver and kidney arterial embolism
11/24/2004	CN1176659C Fluticasone lotion having improved vasoconstrictor activity
11/23/2004	US6822086 Drug-carrier complexes and methods of use thereof
11/23/2004	US6822076 Hybrid ptorin for use in treating allergies and controlling immunogical response
11/23/2004	US6822002 Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
11/23/2004	US6822000 Orthopedic implants or vehicles for the sustained delivery of pharmaceutical, cosmetic and agricultural agents contain hydrogen bonding groups and alpha-hydroxy acid-containing groups
11/23/2004	US6821968 Stable taurolidine electrolyte solutions
11/23/2004	US6821948 Conjugate for mediating cell, compartment or membrane-specific transport of active substances
11/23/2004	US6821934 Flowable preparations of the water-in-oil emulsion type having an increased water content
11/23/2004	US6821531 Fibrous cellulose excipient comprising cellulose ii lattice with bulk density of 0.2-0.5 g/cm3 and tap density of 0.4-0.7 g/cm3; for use as binder, filler, disintegrant in solid dosage forms
11/23/2004	US6821529 Oligo(ethylene glycol)-terminated 3-alkyl-1,2-dithiolane for use as part of support in chemical analysis
11/23/2004	US6821523 Topical administration of pharmacologically active bases in the treatment of warts
11/23/2004	US6821508 Composition and method for topical nail treatment
11/23/2004	CA2317106C Method and composition of an oral preparation of itraconazole
11/23/2004	CA2295061C Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin
11/23/2004	CA2260835C Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
11/23/2004	CA2245766C Compositions useful in the phototherapeutic treatment of proliferative skin disorders
11/23/2004	CA2242035C Compositions useful for transferring therapeutically active substances into a target cell, and their use in gene therapy
11/23/2004	CA2185242C Sustained release tablet containing diclofenac-na
11/23/2004	CA2171963C Dextran esters, the preparation thereof and the use thereof for coating or embedding drugs
11/23/2004	CA2134239C Pretargeting methods and compounds
11/23/2004	CA2107587C Suppression of thromboxane levels by percutaneous administration of aspirin
11/18/2004	WO2004099375A2 Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use therof
11/18/2004	WO2004099307A2 Nanocylinder-modified surfaces
11/18/2004	WO2004099287A1 Polyethylene glycol/polycation block copolymer
11/18/2004	WO2004099135A2 Hiv prodrugs cleavable by cd26
11/18/2004	WO2004098645A1 Immunoglobulin conjugates of autoantigens and their use in the prevention of disease
11/18/2004	WO2004098644A1 Prodrugs cleavable by cd26
11/18/2004	WO2004098643A1 Compositions containing piperacillin and tazobactam useful for injection
11/18/2004	WO2004098642A1 Migraine relief composition and methods of using and forming same
11/18/2004	WO2004098629A1 GnRH CONJUGATES COMPRISING A PHOTOSENSITIZER FOR PHOTODYNAMIC THERAPY
11/18/2004	WO2004098620A1 Activated carbon infusion solution, preparation method therefor and use thereof for the manufacture of drug for treating cancer
11/18/2004	WO2004098615A1 Pharmaceutical composition for intraarticular application in tendon sheaths and periarticular bursae
11/18/2004	WO2004098614A1 Freeze-dried preparation containing methylcobalamin and process for producing the same
11/18/2004	WO2004098575A1 Ultraviolet-shielding type patch
11/18/2004	WO2004098569A1 Micelle delivery system loaded with a pharmaceutical agent
11/18/2004	WO2004098535A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
11/18/2004	WO2004098513A2 Nasal administration of the lh-rh analog leuprolide
11/18/2004	WO2004092231A3 Macromolecules auto-assembled and photopolymerised around carbon nanotubes a method for production and application thereof

1 ... 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 ... 1712